Literature DB >> 22751234

What affects anticoagulation control in patients taking warfarin?

Lindsay Smith1, Edzard Ernst, Paul Ewings, Jeffrey Allen, Caroline Smith, Catherine Quinlan.   

Abstract

BACKGROUND: The ageing population is taking an increasing number of both prescribed and non-prescribed medication. Little is known of the potential for adverse drug reactions between these. Warfarin is a commonly prescribed medication, well known for its potential to cause serious adverse reactions in combination with many prescription medicines. It has been suggested that herbal medicines such as garlic, either as a dietary supplement or in cooking, may also interact with warfarin, resulting in poor international normalised ratio (INR) control. AIM: To determine whether, for patients who take garlic as well as warfarin, the proportion of the INR tests in range is lower than in comparable patients who do not take garlic. DESIGN OF THE STUDY: Retrospective study of patients taking prescribed warfarin.
SETTING: Primary care practices in Somerset and Devon.
METHOD: Three controls (not taking garlic) matched for age, sex, and general practice were compared with each patient self-reporting taking garlic as a supplement. INR results were assessed for the preceding 12 months. Potentially confounding factors were considered, for example diabetes mellitus; all prescribed medication; any bleeding episodes.
RESULTS: No evidence was found to suggest that garlic consumption either as a supplement or in cooking is associated with more frequent haemorrhagic complications or less control of INR. Poor INR control may, however, be associated with taking larger numbers of prescription medicines, particularly during prescription changes.
CONCLUSION: Further research would be warranted into whether increased INR monitoring is needed when drug changes are made. These data render clinically significant interactions between warfarin and garlic intake unlikely.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22751234      PMCID: PMC2714782          DOI: 10.3399/bjgp09X453800

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  24 in total

1.  An evidence-based review of the 10 most commonly used herbs.

Authors:  C Mar; S Bent
Journal:  West J Med       Date:  1999-09

2.  The BBC survey of complementary medicine use in the UK.

Authors:  E Ernst; A White
Journal:  Complement Ther Med       Date:  2000-03       Impact factor: 2.446

Review 3.  Herbal medicines and perioperative care.

Authors:  M K Ang-Lee; J Moss; C S Yuan
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome.

Authors:  K H Humphries; C R Kerr; S J Connolly; G Klein; J A Boone; M Green; R Sheldon; M Talajic; P Dorian; D Newman
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

Review 5.  Prescribing for older people.

Authors:  James C Milton; Ian Hill-Smith; Stephen H D Jackson
Journal:  BMJ       Date:  2008-03-15

Review 6.  Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use.

Authors:  V Evans
Journal:  J Neurosci Nurs       Date:  2000-08       Impact factor: 1.230

Review 7.  Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials.

Authors:  C Stevinson; M H Pittler; E Ernst
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

Review 8.  Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence.

Authors:  L P Vaes; P A Chyka
Journal:  Ann Pharmacother       Date:  2000-12       Impact factor: 3.154

9.  Thromboxane-B(2) levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion.

Authors:  M Thomson; T Mustafa; M Ali
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000-10       Impact factor: 4.006

Review 10.  Interactions between herbal medicines and prescribed drugs: a systematic review.

Authors:  A A Izzo; E Ernst
Journal:  Drugs       Date:  2001       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.